Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin-17 receptor (IL-17R) is a cytokine receptor that binds members of the IL-17 family, primarily mediating proinflammatory responses. It plays a crucial role in host defense against extracellular pathogens and is implicated in the pathogenesis of various autoimmune and inflammatory diseases. Functional receptors are typically heteromeric complexes formed by combinations of IL‑17RA, IL‑17RB, IL‑17RC, IL‑17RD, and IL‑17RE subunits. Upon ligand binding, these receptors activate several intracellular signaling cascades including TRAF6, MAP kinases, and NF–κB, leading to induction of chemokines, G-CSF, antimicrobial peptides, and pro-inflammatory cytokines.
IL-17R antagonists block IL-17 signaling by preventing ligand-receptor interaction or downstream signaling events.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 17 Receptor (IL-17R).